Research programme: 8-hydroxyquinoline derivativesAlternative Names: 8-hydroxyquinoline derivatives - research programme; Hydroxyquinoline derivatives - research programme
Latest Information Update: 24 Apr 2002
At a glance
- Originator Nonindustrial source
- Mechanism of Action DNA synthesis inhibitors; RNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 02 Sep 1999 New profile
- 02 Sep 1999 Preclinical development for Cancer in Taiwan (Unknown route)